Liya Pi1, Seh-Hoon Oh, Thomas Shupe, Bryon E Petersen. 1. Department of Pathology, Immunology and Laboratory Medicine, University of Florida, College of Medicine, Gainesville 32610-0275, USA.
Abstract
BACKGROUND & AIMS: Recruitment and proliferation of Thy-1+ oval cells is a hallmark of liver regeneration after 2-acetylaminofluorene (2-AAF)/partial hepatectomy (PHx) in rats. To understand the molecular mechanism underlying this process, we investigated the role of connective tissue growth factor (CTGF), one of the candidate genes differentially expressed in Thy-1+ oval cells, in this liver injury model. METHODS: Northern and Western analyses were performed to examine the induction of CTGF in total liver homogenate. Quantitative real-time polymerase chain reaction (PCR), immunofluorescent staining, and in situ hybridization were performed to confirm the expression and localization of CTGF in Thy-1+ oval cells. Finally, a known inhibitor of CTGF synthesis, Iloprost, was administered to 2-AAF/PHx treated rats to investigate the effect of Iloprost on oval cell response. RESULTS: CTGF was found to be up-regulated at both the RNA and protein levels and occurred concurrently with an up-regulation of transforming growth factor beta1 (TGF-beta1). Sorted Thy-1+ oval cells expressed a high level of CTGF gene in a quantitative PCR assay. Colocalization of Thy-1 antigen and ctgf signals by in situ hybridization further confirmed that Thy-1+ oval cells were a source of CTGF. Iloprost administration blocked CTGF induction in treated animals but did not affect TGF-beta1 expression. The inhibition of CTGF induction by Iloprost was associated with a significant decrease in oval cell proliferation and a lower level of alpha-fetoprotein expression as compared with control animals. CONCLUSIONS: These results show that CTGF induction is important for robust oval cell response after 2-AAF/PHx treatment in rats.
BACKGROUND & AIMS: Recruitment and proliferation of Thy-1+ oval cells is a hallmark of liver regeneration after 2-acetylaminofluorene (2-AAF)/partial hepatectomy (PHx) in rats. To understand the molecular mechanism underlying this process, we investigated the role of connective tissue growth factor (CTGF), one of the candidate genes differentially expressed in Thy-1+ oval cells, in this liver injury model. METHODS: Northern and Western analyses were performed to examine the induction of CTGF in total liver homogenate. Quantitative real-time polymerase chain reaction (PCR), immunofluorescent staining, and in situ hybridization were performed to confirm the expression and localization of CTGF in Thy-1+ oval cells. Finally, a known inhibitor of CTGF synthesis, Iloprost, was administered to 2-AAF/PHx treated rats to investigate the effect of Iloprost on oval cell response. RESULTS:CTGF was found to be up-regulated at both the RNA and protein levels and occurred concurrently with an up-regulation of transforming growth factor beta1 (TGF-beta1). Sorted Thy-1+ oval cells expressed a high level of CTGF gene in a quantitative PCR assay. Colocalization of Thy-1 antigen and ctgf signals by in situ hybridization further confirmed that Thy-1+ oval cells were a source of CTGF. Iloprost administration blocked CTGF induction in treated animals but did not affect TGF-beta1 expression. The inhibition of CTGF induction by Iloprost was associated with a significant decrease in oval cell proliferation and a lower level of alpha-fetoprotein expression as compared with control animals. CONCLUSIONS: These results show that CTGF induction is important for robust oval cell response after 2-AAF/PHx treatment in rats.
Authors: R Stratton; X Shiwen; G Martini; A Holmes; A Leask; T Haberberger; G R Martin; C M Black; D Abraham Journal: J Clin Invest Date: 2001-07 Impact factor: 14.808
Authors: K Ujike; T Shinji; S Hirasaki; H Shiraha; M Nakamura; T Tsuji; N Koide Journal: Biochem Biophys Res Commun Date: 2000-10-22 Impact factor: 3.575
Authors: M Golding; C E Sarraf; E N Lalani; T V Anilkumar; R J Edwards; P Nagy; S S Thorgeirsson; M R Alison Journal: Hepatology Date: 1995-10 Impact factor: 17.425
Authors: A Igarashi; K Nashiro; K Kikuchi; S Sato; H Ihn; M Fujimoto; G R Grotendorst; K Takehara Journal: J Invest Dermatol Date: 1996-04 Impact factor: 8.551
Authors: Liya Pi; Anitha K Shenoy; Jianwen Liu; Seungbum Kim; Nikole Nelson; Huiming Xia; William W Hauswirth; Bryon E Petersen; Gregory S Schultz; Edward W Scott Journal: FASEB J Date: 2012-05-18 Impact factor: 5.191